Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet [20 mg] versus desloratadine capsule [5 mg]: a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults
- PMID: 18201596
- DOI: 10.1016/s0149-2918(07)00408-0
Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet [20 mg] versus desloratadine capsule [5 mg]: a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults
Comment on
-
Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.Clin Ther. 2007 May;29(5):814-822. doi: 10.1016/j.clinthera.2007.05.001. Clin Ther. 2007. PMID: 17697901 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
